Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4497) 4497
Publication (459) 459
Book Chapter (56) 56
Trade Publication Article (29) 29
Book Review (26) 26
Magazine Article (26) 26
Newspaper Article (19) 19
Conference Proceeding (7) 7
Dissertation (4) 4
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3764) 3764
hematology (2879) 2879
unrelated donors (2836) 2836
transplantation (2653) 2653
index medicus (2307) 2307
female (2244) 2244
male (2199) 2199
adult (1939) 1939
immunology (1802) 1802
middle aged (1559) 1559
adolescent (1407) 1407
bone-marrow-transplantation (1387) 1387
oncology (1277) 1277
versus-host-disease (1159) 1159
transplantation, homologous (1136) 1136
hematopoietic stem cells (1077) 1077
child (1057) 1057
stem cells (1009) 1009
hematopoietic stem cell transplantation (979) 979
treatment outcome (929) 929
retrospective studies (836) 836
stem-cell transplantation (819) 819
aged (817) 817
child, preschool (805) 805
leukemia (688) 688
hematopoietic stem cell transplantation - methods (687) 687
young adult (659) 659
histocompatibility testing (649) 649
graft vs host disease - prevention & control (638) 638
transplantation conditioning - methods (631) 631
hematology, oncology and palliative medicine (613) 613
infant (605) 605
unrelated donor (604) 604
bone-marrow (583) 583
bone marrow (555) 555
survival analysis (544) 544
bone marrow transplantation (542) 542
risk factors (539) 539
hematopoietic stem cell transplantation - adverse effects (516) 516
tissue donors (502) 502
health aspects (497) 497
graft vs host disease - etiology (494) 494
disease-free survival (468) 468
children (467) 467
recipients (463) 463
analysis (458) 458
acute myeloid-leukemia (452) 452
hematologic neoplasms - therapy (451) 451
hematologic malignancies (434) 434
survival (433) 433
recurrence (416) 416
survival rate (408) 408
transplantation conditioning (408) 408
mortality (389) 389
graft vs host disease - immunology (387) 387
outcomes (386) 386
stem cell transplantation (381) 381
care and treatment (377) 377
research (377) 377
graft survival (367) 367
engraftment (355) 355
graft vs host disease - mortality (349) 349
article (323) 323
acute disease (318) 318
fetal blood - cytology (318) 318
animals (302) 302
leukemia, myeloid, acute - therapy (301) 301
bone-marrow transplantation (293) 293
follow-up studies (293) 293
acute-leukemia (290) 290
cord blood (290) 290
pediatrics (281) 281
graft-versus-host disease (280) 280
cord blood transplantation (277) 277
antithymocyte globulin (276) 276
cord blood stem cell transplantation (276) 276
cancer (274) 274
adults (271) 271
siblings (269) 269
graft (268) 268
versus-host disease (266) 266
alleles (263) 263
immunosuppressive agents - therapeutic use (263) 263
cord blood stem cell transplantation - methods (259) 259
blood (258) 258
hla antigens - immunology (258) 258
histocompatibility antigens (256) 256
time factors (253) 253
hla histocompatibility antigens (251) 251
total-body irradiation (246) 246
peripheral-blood (244) 244
prognosis (244) 244
risk (240) 240
allogeneic transplantation (238) 238
histocompatibility (235) 235
umbilical-cord blood (234) 234
placental-blood (231) 231
infant, newborn (230) 230
t cells (226) 226
fetal blood (225) 225
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4486) 4486
French (27) 27
German (24) 24
Chinese (21) 21
Russian (16) 16
Japanese (11) 11
Korean (9) 9
Spanish (9) 9
Polish (7) 7
Czech (2) 2
Italian (2) 2
Dutch (1) 1
Slovenian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text East Meets West—Impact of Ethnicity on Donor Match Rates in the Ezer Mizion Bone Marrow Donor Registry
by Halagan, Michael and Manor, Sigal and Shriki, Nira and Yaniv, Isaac and Zisser, Bracha and Madbouly, Abeer and Maiers, Martin and Stein, Jerry
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 23, Issue 8, pp. 1381 - 1386
Highlights • We report on the likelihood of HLA matching provided by donors from the Ezer Mizion Bone Marrow Donor Registry (BMDR) for patients seeking... 
Hematology, Oncology and Palliative Medicine | Registry modeling | Match rates | HLA | Haplotype and allele frequencies | Jewish population | Bone marrow donor registry | Haplotype and allele | POPULATION | MAXIMUM-LIKELIHOOD | UNRELATED DONOR | HAPLOTYPE FREQUENCIES | BLOOD-DONORS | ISRAEL | HLA-A | IMMUNOLOGY | NATIONAL REGISTRY | TRANSPLANTATION | PROBABILITY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | frequencies | Donor Selection | Humans | Middle Aged | Child, Preschool | Male | Adolescent | Adult | Female | Registries | Aged | HLA Antigens | Tissue Donors | Continental Population Groups | Child | Bone marrow | Transplantation | Analysis | Stem cells | Resveratrol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Decision analysis for donor selection in stem cell transplantation - HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor
by Kanda, J and Fuji, S and Kato, S and Takami, A and Tanaka, J and Miyamura, K and Ohashi, K and Fukuda, T and Ozawa, Y and Kanamori, H and Eto, T and Kobayashi, N and Iwato, K and Morishima, Y and Sakamak, H and Atsuta, Y and Kanda, Y and Adult AML Working Grp and Source Working Grp and Adult ALL Working Grp Japan Soc He and HLA Working Grp and Donor/Source Working Group and Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation and Adult AML Working Group and HLA Working Group and On behalf of the HLA Working Group, the Donor/Source Working Group, the Adult AML Working Group, and the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation
Blood Cancer Journal, ISSN 2044-5385, 01/2014, Volume 4, Issue 12, pp. e263 - e263
Risk of relapse during the unrelated donor coordination period biases comparisons between allogeneic hematopoietic stem cell transplantation from an HLA 8 of 8... 
SURVIVAL | ADULT PATIENTS | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | IDENTICAL SIBLINGS | 1ST RELAPSE | DIRECTION | ACUTE MYELOID-LEUKEMIA | MARROW-TRANSPLANTATION | VERSUS-HOST-DISEASE | Histocompatibility Testing | Humans | Middle Aged | Decision Support Techniques | Donor Selection - methods | Hematopoietic Stem Cell Transplantation | Male | Allografts | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Adolescent | Adult | Female | Unrelated Donors | Aged | HLA Antigens | Leukemia, Myeloid, Acute - therapy | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Five-year follow-up after live donor nephrectomy - cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteria
by Janki, S and Dols, L.F and Timman, R and Mulder, E.E and Dooper, I.M.M and Wetering, J. van de and Ijzermans, J.N.M
Transplant International, ISSN 0934-0874, 2017, Volume 30, Issue 3, pp. 266 - 276
To establish the outcome of live kidney donors 5 years after donation, we investigated the risk for progressive renal function decline and quality of life... 
kidney | renal function | safety | follow‐up | live donation | follow-up | UNITED-STATES | SURGERY | DONATION | UNRELATED DONORS | SINGLE-CENTER | TRANSPLANTATION | GLOMERULAR-FILTRATION-RATE | SF-36 HEALTH SURVEY | LIVING KIDNEY DONORS | LONG-TERM SAFETY | STAGE RENAL-DISEASE | Glomerular Filtration Rate | Cross-Sectional Studies | Donor Selection | Follow-Up Studies | Humans | Middle Aged | Tissue and Organ Procurement | Male | Hypertension - physiopathology | Nephrectomy - methods | Nephrectomy - adverse effects | Quality of Life | Adult | Female | Aged | Living Donors - psychology | Longitudinal Studies | Hypertension | Transplantation of organs, tissues, etc | Disease susceptibility | Chronic kidney failure | Analysis | Donation of organs, tissues, etc
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Comparing the cost of preparing matched unrelated donor and TCR α+β+/CD19+ depleted donor material for pediatric hematopoietic stem cell transplants in Australia
by Sambeek, Björn and Flattery, Martin and Mitchell, Richard and De Abreu Lourenco, Richard
Pediatric Transplantation, ISSN 1397-3142, 11/2018, Volume 22, Issue 7, pp. e13279 - n/a
Use of TCR α + β + / CD 19 + depletion in a pediatric setting has improved the utility of haploidentical donor material, resulting in better rates of... 
pediatric transplants | costs | graft acquisition and preparation | PEDIATRICS | CHILDREN | TRANSPLANTATION | Biomarkers - metabolism | Lymphocyte Depletion - economics | Humans | Transplantation, Haploidentical - economics | Hematopoietic Stem Cell Transplantation - economics | Transplantation, Haploidentical - methods | T-Lymphocytes - metabolism | Health Care Costs - statistics & numerical data | Unrelated Donors | Antigens, CD19 - metabolism | Hematopoietic Stem Cell Transplantation - methods | Australia | Lymphocyte Depletion - methods | Graft-versus-host reaction | Pediatrics | Costs | CD19 antigen | Transplants & implants | Laboratories | Mortality | Prophylaxis | T cell receptors | Hematopoietic stem cells | Morbidity | Hemopoiesis | T-cell receptor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study
by Switzer, Galen E and Bruce, Jessica and Kiefer, Deidre M and Kobusingye, Hati and Drexler, Rebecca and Besser, RaeAnne M and Confer, Dennis L and Horowitz, Mary M and King, Roberta J and Shaw, Bronwen E and Riches, Marcie and Hayes-Lattin, Brandon and Linenberger, Michael and Bolwell, Brian and Rowley, Scott D and Litzow, Mark R and Pulsipher, Michael A
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 01/2017, Volume 23, Issue 1, pp. 165 - 171
The increasing number of older adults with blood-related disorders and the introduction of reduced-intensity conditioning regimens has led to increases in... 
Related donation | Hematopoietic stem cell (HSC) donation | HSC donor health-related quality of life (HRQoL) | IMPACT | RECOMMENDATIONS | UNRELATED DONORS | ATTRITION | IMMUNOLOGY | HEMATOLOGY | BONE-MARROW DONATION | TRANSPLANTATION | AGE | Age Factors | Humans | Middle Aged | Peripheral Blood Stem Cells | Mental Health | Young Adult | Adolescent | Quality of Life | Adult | Aged | Tissue Donors | Hematopoietic Stem Cells | Siblings | Safety and security measures | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Related hematopoietic cell donor care: Is there a role for unrelated donor registries
by Anthias, C and Van Walraven, S.M and Sørensen, B.S and De Faveri, G.N and Fechter, M and Cornish, J and Bacigalupo, A and Muller, C and Boo, M and Shaw, B.E
Bone Marrow Transplantation, ISSN 0268-3369, 05/2015, Volume 50, Issue 5, pp. 637 - 641
In almost half of allogeneic hematopoietic progenitor cell (HPC) transplants, a related donor (RD) is used, yet a lack of standardized guidelines means that... 
COLLECTION | DONATION | ONCOLOGY | IMMUNOLOGY | HEMATOLOGY | TRANSPLANTATION | BLOOD | Hematopoietic Stem Cell Transplantation | Registries | Unrelated Donors | Congresses as Topic | Humans | Hematopoietic Stem Cells | Care and treatment | Usage | Stem cells | Bone marrow | Transplantation | Medical screening | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Stem-cell transplantation in children with acute lymphoblastic leukemia:A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial
by Peters, Christina and Matthes-Martin, Susanne and Poetschger, Ulrike and Schrappe, Martin and Schrauder, André and Von Stackelberg, Arend and Ebell, Wolfram and Bader, Peter and Klingebiel, Thomas and Lang, Peter and Sykora, Karl-Walter and Zimmerman, Martin and Schrum, Johanna and Kremens, Bernhard and Ehlert, Karoline and Albert, Michael H and Meisel, Roland and Holter, Wolfgang and Strahm, Brigitte and Gruhn, Bernd and Schulz, Ansgar and Woessmann, Wilhelm and Gungor, Tayfun
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 11, pp. 1265 - 1274
Purpose Although hematopoietic stem-cell transplantation is widely performed in children with high-risk acute lymphoblastic leukemia (ALL), the influence of... 
TOTAL-BODY IRRADIATION | HLA CLASS-I | ONCOLOGY | BONE-MARROW-TRANSPLANTATION | ADOLESCENTS | RISK | 2ND REMISSION | CONDITIONING REGIMENS | OUTCOMES | VERSUS-HOST-DISEASE | MINIMAL RESIDUAL DISEASE | Recurrence | Whole-Body Irradiation | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Prospective Studies | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Humans | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Living Donors | HLA Antigens - genetics | Hematopoietic Stem Cell Transplantation - mortality | Transplantation, Homologous | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Unrelated Donors | Transplantation Conditioning - methods | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | Infant, Newborn | Siblings | Histocompatibility Testing | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | HLA Antigens - immunology | Etoposide - administration & dosage | Treatment Outcome | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Hematopoietic Stem Cell Transplantation - methods | Histocompatibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Impact of donor activating KIR genes on HSCT outcome in C1-ligand negative myeloid disease patients transplanted with unrelated donors - A retrospective study
by Neuchel, Christine and Fürst, Daniel and Niederwieser, Dietger and Bunjes, Donald and Tsamadou, Chrysanthi and Wulf, Gerald and Pfreundschuh, Michael and Wagner, Eva and Stuhler, Gernot and Einsele, Hermann and Schrezenmeier, Hubert and Mytilineos, Joannis
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, p. e0169512
Natural Killer cells (NK) are lymphocytes with the potential to recognize and lyse cells which escaped T-cell mediated lysis due to their aberrant HLA... 
NATURAL-KILLER-CELLS | HLA CLASS-I | LEUKEMIA PATIENTS | MARROW | NK CELLS | MULTIDISCIPLINARY SCIENCES | DOWN-REGULATION | STEM-CELL TRANSPLANTATION | LIGAND INCOMPATIBILITY | RECEPTORS | MOLECULES | Hematologic Neoplasms - therapy | Receptors, KIR - genetics | Humans | Middle Aged | Complement C1 - metabolism | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Young Adult | Adolescent | Killer Cells, Natural - immunology | Adult | Female | Ligands | Unrelated Donors | Aged | Retrospective Studies | Cohort Studies | Killer cells | Care and treatment | Myelocytic leukemia | Patient outcomes | Genetic aspects | Nonlymphoid leukemia | Transplantation | Research | Health aspects | Hematopoietic stem cells | Blood transfusions | Haplotypes | Transplants & implants | Disease | Leukemia | Genes | Stem cell transplantation | Oncology | Immunoglobulin-like receptors | Lymphocytes T | Receptors | Lymphocytes | Killer cell immunoglobulin-like receptors | Bone marrow | Natural killer cells | Antigens | Myeloid cells | Immunoglobulins | Potassium channels (inwardly-rectifying) | Hematology | Search algorithms | Immunoproliferative diseases | Patients | Survival | Hemopoiesis | Medicine | Survival analysis | Hospitals | Donors | Genotyping | Lysis | Stem cells | Histocompatibility antigen HLA | Aberration
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Precision in donor selection: Identifying ideal stem-cell donors through their T cells
by Widman, Adam and Reshef, Ran
Experimental Hematology, ISSN 0301-472X, 2016, Volume 44, Issue 11, pp. 1020 - 1023
HLA-identical siblings have always been considered ideal donors for allogeneic hematopoietic stem-cell transplantation (allo-HSCT) in the treatment of... 
Hematology, Oncology and Palliative Medicine | Advanced Basic Science | MEDICINE, RESEARCH & EXPERIMENTAL | ENGRAFTMENT | UNRELATED DONORS | BONE-MARROW | COMPARTMENTALIZATION | IMPROVED SURVIVAL | RATIO | MALIGNANCIES | RECIPIENTS | HEMATOLOGY | TRANSPLANTATION | AGE | Age Factors | Donor Selection | Humans | Treatment Outcome | Hematopoietic Stem Cells - metabolism | Transplantation, Homologous | CD4-CD8 Ratio | Hematopoietic Stem Cells - immunology | Animals | T-Lymphocytes - metabolism | Hematopoietic Stem Cell Transplantation - adverse effects | Graft vs Host Disease - prevention & control | T-Lymphocytes - immunology | Transplantation Immunology | Graft vs Host Disease - etiology | Precision Medicine - methods | Analysis | Stem cells | Organ transplant recipients | Bone marrow | Transplantation | T cells | Hematopoietic stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
by Kollman, Craig and Spellman, Stephen R and Zhang, Mei-Jie and Hassebroek, Anna and Anasetti, Claudio and Antin, Joseph H and Champlin, Richard E and Confer, Dennis L and DiPersio, John F and Fernandez-Viña, Marcelo and Hartzman, Robert J and Horowitz, Mary M and Hurley, Carolyn K and Karanes, Chatchada and Maiers, Martin and Mueller, Carlheinz R and Perales, Miguel-Angel and Setterholm, Michelle and Woolfrey, Ann E and Yu, Neng and Eapen, Mary
Blood, ISSN 0006-4971, 01/2016, Volume 127, Issue 2, pp. 260 - 267
There are >24 million registered adult donors, and the numbers of unrelated donor transplantations are increasing. The optimal strategy for prioritizing among... 
RISK-FACTORS | GRAFTS | BONE-MARROW | LEUKEMIA | STEM-CELL TRANSPLANTATION | RETROSPECTIVE ANALYSIS | RECIPIENTS | SELECTION | HEMATOLOGY | BLOOD | REGISTRY | Hematologic Neoplasms - therapy | Histocompatibility Testing | Hematologic Neoplasms - mortality | Humans | Middle Aged | Unrelated Donors - statistics & numerical data | Male | Hematopoietic Stem Cell Transplantation - mortality | Graft vs Host Disease - immunology | Histocompatibility - immunology | Young Adult | Graft vs Host Disease - mortality | Adolescent | Hematopoietic Stem Cell Transplantation - adverse effects | Survival Analysis | Adult | Female | Hematologic Neoplasms - immunology | Transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
by Gaballa, Sameh and Ge, Isabell and El Fakih, Riad and Brammer, Jonathan E and Kongtim, Piyanuch and Tomuleasa, Ciprian and Wang, Sa A and Lee, Dean and Petropoulos, Demetrios and Cao, Kai and Rondon, Gabriela and Chen, Julianne and Hammerstrom, Aimee and Lombardi, Lindsey and Alatrash, Gheath and Korbling, Martin and Oran, Betul and Kebriaei, Partow and Ahmed, Sairah and Shah, Nina and Rezvani, Katayoun and Marin, David and Bashir, Qaiser and Alousi, Amin and Nieto, Yago and Qazilbash, Muzaffar and Hosing, Chitra and Popat, Uday and Shpall, Elizabeth J and Khouri, Issa and Champlin, Richard E and Ciurea, Stefan O
Cancer, ISSN 0008-543X, 11/2016, Volume 122, Issue 21, pp. 3316 - 3326
After transplantation, combined cyclophosphamide, tacrolimus, and mycophenolate is an effective graft‐versus‐host disease prophylaxis strategy for patients... 
hematologic malignancies | haploidentical transplantation | graft‐versus‐host disease | post‐transplantation cyclophosphamide | 9/10 matched unrelated donors | post-transplantation cyclophosphamide | graft-versus-host disease | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | FLUDARABINE | SINGLE-AGENT | PROPHYLAXIS | ONCOLOGY | HLA-IDENTICAL SIBLINGS | LEUKEMIA | OUTCOMES | MELPHALAN | Hematologic Neoplasms - therapy | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Feasibility Studies | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Unrelated Donors | Drug Therapy, Combination | Graft vs Host Disease - etiology | Histocompatibility Testing | Tacrolimus - therapeutic use | Mycophenolic Acid - therapeutic use | Adolescent | Graft vs Host Disease - prevention & control | Aged | Transplantation Conditioning | Prevention | Usage | Cyclophosphamide | Clinical trials | Graft versus host reaction | Transplantation | Hematopoietic stem cells | 10 matched unrelated donors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: Results from BMTCTN 0201
by Waller, Edmund K and Logan, Brent R and Harris, Wayne A. C and Devine, Steven M and Porter, David L and Mineishi, Shin and McCarty, John M and Gonzalez, Corina E and Spitzer, Thomas R and Krijanovski, Oleg I and Linenberger, Michael L and Woolfrey, Ann and Howard, Alan and Wu, Juan and Confer, Dennis L and Anasetti, Claudio
Journal of Clinical Oncology, ISSN 0732-183X, 08/2014, Volume 32, Issue 22, pp. 2365 - 2372
Purpose To characterize relationships between specific immune cell subsets in bone marrow (BM) or granulocyte colony-stimulating factor-mobilized peripheral... 
IMMUNITY | ONCOLOGY | BONE-MARROW | INDOLEAMINE 2,3-DIOXYGENASE | MOUSE | CCR9 | INDUCTION | LEUKEMIA | VERSUS-HOST-DISEASE | MOLECULES | PERSIST | Myeloproliferative Disorders - therapy | Dendritic Cells - immunology | Humans | Middle Aged | Child, Preschool | Leukemia - therapy | Infant | Male | Survival Rate | Bone Marrow Transplantation - methods | Young Adult | Myelodysplastic Syndromes - therapy | T-Lymphocytes - cytology | Adolescent | Survival Analysis | Adult | Female | T-Lymphocytes - immunology | Unrelated Donors | Dendritic Cells - cytology | Primary Myelofibrosis - therapy | Child | Infant, Newborn | Original Reports | To6 | Bone1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Donor and recipient age, gender and ABO incompatibility regardless of donor source: Validated criteria for donor selection for haematopoietic transplants
by Wang, Y and Wu, D.-P and Liu, Q.-F and Xu, L.-P and Liu, K.-Y and Zhang, X.-H and Xu, Y and Huang, F and Huang, X.-J
Leukemia, ISSN 0887-6924, 02/2018, Volume 32, Issue 2, pp. 492 - 498
Prior data indicate similar outcomes after transplants from human leukocyte antigen (HLA)-haplotype-matched relatives, HLA-identical siblings and HLA-matched... 
RISK-FACTORS | ONCOLOGY | UNRELATED DONOR | BONE-MARROW-TRANSPLANTATION | MINOR HISTOCOMPATIBILITY ANTIGENS | POSTTRANSPLANTATION CYCLOPHOSPHAMIDE | ACUTE MYELOID-LEUKEMIA | STEM-CELL TRANSPLANTATION | HEMATOLOGY | VERSUS-HOST-DISEASE | CHRONIC GRAFT | HEMATOLOGIC MALIGNANCIES | Care and treatment | Histocompatibility antigens | Patient outcomes | HLA histocompatibility antigens | Acute leukemia | Health aspects | Blood groups | Blood transfusion | Incompatibility | Haplotypes | Transplants & implants | Leukemia | Transplants | ABO system | Risk analysis | Risk factors | White blood cells | Thymocytes | Globulins | Granulocyte colony-stimulating factor | Colony-stimulating factor | Remission | Histocompatibility antigen HLA | Leukocytes (granulocytic) | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights